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reveal conserved RNA structures and a novel
stable intronic sequence RNA
Walter N Moss and Joan A Steitz*Abstract
Background: Epstein-Barr virus (EBV) is a human herpesvirus implicated in cancer and autoimmune disorders. Little
is known concerning the roles of RNA structure in this important human pathogen. This study provides the first
comprehensive genome-wide survey of RNA and RNA structure in EBV.
Results: Novel EBV RNAs and RNA structures were identified by computational modeling and RNA-Seq analyses of
EBV. Scans of the genomic sequences of four EBV strains (EBV-1, EBV-2, GD1, and GD2) and of the closely related
Macacine herpesvirus 4 using the RNAz program discovered 265 regions with high probability of forming
conserved RNA structures. Secondary structure models are proposed for these regions based on a combination of
free energy minimization and comparative sequence analysis. The analysis of RNA-Seq data uncovered the first
observation of a stable intronic sequence RNA (sisRNA) in EBV. The abundance of this sisRNA rivals that of the
well-known and highly expressed EBV-encoded non-coding RNAs (EBERs).
Conclusion: This work identifies regions of the EBV genome likely to generate functional RNAs and RNA
structures, provides structural models for these regions, and discusses potential functions suggested by the
modeled structures. Enhanced understanding of the EBV transcriptome will guide future experimental analyses
of the discovered RNAs and RNA structures.
Keywords: Epstein-Barr virus (EBV), Herpesvirus, RNA, RNA structure, Non-coding RNA (ncRNA), RNA-Seq,
Bioinformatics, W repeat, sisRNA, RNA editingBackground
Epstein-Barr virus (EBV) is widely disseminated in the
human population. Upwards of 95% of the adult human
population is infected with EBV [1]. EBV is implicated in
a number of different cancers, including Hodgkin’s dis-
ease [2], nasopharyngeal carcinoma [3], hepatocellular
carcinomas [4], lymphoepithelioma-like carcinomas [5],
some breast cancers [6], and in autoimmune disorders
such as Sjögren’s syndrome [7], dermatomyositis [8],
lupus [9], rheumatoid arthritis [10], and multiple scler-
osis [11]. EBV was the first cancer-associated virus to be
discovered when in 1964 [12] it was isolated from tumors
occurring in African children (Burkitt’s lymphoma [13]).* Correspondence: joan.steitz@yale.edu
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Medical Institute, Yale University School of Medicine, New Haven,
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Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumDespite intense investigation for more than 50 years, the
precise roles played by the virus in these diseases remains
to be elucidated.
The ~170000 bp genome of EBV is a linear double-
stranded (ds)DNA that circularizes to form an episome
in the host cell nucleus. Infection occurs by entry of the
EBV virion into human host epithelial cells and initially
proceeds via an aggressive lytic phase. The virus migrates
to B cells where it causes persistent lifelong infections
marked by extended periods of latency with interspersed
lytic reactivation [14]. EBV latency proceeds via three dis-
tinct programs, each expressing a different set of coding
and non-coding viral gene products. Viral latent gene
products rewire B cells to evade the host immune system
and propagate the virus [15]. In a manner not yet fully
understood, this rewiring increases the tumorigenic poten-
tial of EBV-infected cells, including making infected cellstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cancerous cells [16].
The EBV transcriptome is complex, consisting of mul-
tiple pre-mRNA transcripts that undergo extensive alterna-
tive splicing events and can, at various states of infection,
yield different sets of gene products [17]. Two well-studied
EBV-encoded ncRNAs (EBER1 and EBER2) are known
to be expressed throughout infection [18], as are subsets
of as many as 50 different EBV-encoded microRNAs
(miRNAs) [19,20]. Although the precise functions of the
EBERs have remained obscure, they are the most highly
expressed RNAs in EBV-infected cells (~107 copies per
cell [18]). Roles in cancer have been proposed [21] and
the EBERs are capable of inducing tumors in immune-
suppressed mice [22]. Both EBERs form ribonucleopro-
tein complexes [23-26], including host proteins, and
adopt well-defined secondary structures [27]. Except for
the EBERs, RNA structure is a relatively understudied
aspect of EBV virology; an analysis of RNA secondary
structure in EBV could enable significant advances in un-
derstanding this important human pathogen.
RNA secondary structure plays important roles in
many viruses, mediating functions as diverse as transla-
tion initiation [28], catalysis [29], viral genome packaging
[30], alternative splicing [31,32], interactions with the
host innate immune system [33], RNA lifetime/stability
[34-36], and regulation of gene expression [37]. The dis-
covery of RNA structure is an active area of research
[38-40] and is aided by the availability of sophisticated
non-coding (nc)RNA-discovery algorithms [41-43]. A
successful strategy for discovering conserved RNA struc-
tures is implemented in the program RNAz [44]. In this
approach, homologous sequences are aligned and divided
into fragments. For each fragment, calculated parameters
that include measures of the thermodynamic stability







Figure 1 Phylogenic relationships of analyzed viruses. (Left) Phylogene
gamma), where the gamma sub-family is further divided into two genera:
was generated from data in [51]. (Right) Breakdown of the gamma herpesv
(100 replicates) was based on the conserved herpesvirus DNA polymerase
(KSHV), a gamma-1 herpesvirus, is used as an outgroup to illustrate the phy
and GD2) and two other lymphocryptoviruses used in this study [Macacine
was generated using the Geneious program.are used to make predictions based on a support vector
machine (SVM) trained on known ncRNAs, which gener-
ates a probability classifier (p-class, scale of 0.0 to 1.0) for
the fragment containing conserved secondary structure.
The RNAz approach has been used to discover RNA sec-
ondary structures in a number of viruses [38,46-48].
Results and discussion
Global findings
RefSeq genomes (~170 kbp long) from four EBV strains
(NC_007605.1, NC_009334.1, AY961628.3, HQ020558.1)
and one from the closely-related (Figure 1) Macacine
herpesvirus 4 (MHV4, NC_006146.1; also known as rhe-
sus lymphocryptovirus) were aligned using the MAFFT
alignment program [49,50]. The average pairwise se-
quence identity (APSI) of the alignment is 84.8%; the
four EBV strains were close in sequence (APSI of 95.6%),
while MHV4 had an APSI of 68.6% versus EBV.
Across the entire EBV genome the z-score average
is -0.19 and the average p-class is 0.13. RNAz discovered
265 regions that map to known transcripts from the EBV
genome (named locus 1 to 265 in Additional files 1 and 2)
and have strong evidence of locally conserved and stable
RNA structure. These regions (average length ~200 nt)
are comprised of overlapping windows with high predicted
probability of generating conserved RNA structure. The
average p-class for the set of predictions was 0.91 with
minimum and maximum values of 0.61 and 1.00, respect-
ively (Additional file 1). The thermodynamic z-score is an
important component in determining the p-class. This par-
ameter reflects the thermodynamic stability of the native
sequence predicted structure versus that of random se-
quence [45] (e.g. measures greater than expected folding
stability). For predicted structured regions in EBV RNA,
the average z-score was -2.38 with minimum and max-







tic tree showing the three herpesviridae sub-families (alpha, beta, and
gamma-1 (Rhadinovirus) and gamma-2 (Lymphocryptovirus). The tree
irus branch shown on the left. The consensus neighbor-joining tree
catalytic subunit (DPOL). Kaposi’s sarcoma-associated herpesvirus
logenetic relationships between four EBV strains (EBV-1, EBV-2, GD1,
herpesvirus 4 (MHV4) and Callitrichine herpesvirus 3 (CaHV3)]. The tree
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tions that may occur outside the overlapped prediction
windows.
Identification of known EBV ncRNAs
The genomic region specifying EBER1 occurs within
locus 12 (Additional file 1). The structure model derived
for EBER1 (Figure 2A) is almost identical to the model
in the Rfam database (ID# RF01789). A single base pair
in the Rfam model, between nt 6760 and 6770, is shifted
to form a pair between 6646 and 6770, and the predicted
closing AU pair of this hairpin is open in the Rfam
model (Figure 2A). Additionally, C6649 is in a bulge-
loop in the Rfam model, but the insertion of a G residue
across from this nt allows a GC pair to form. EBER2,
surprisingly, does not occur in an RNAz-predicted locus.
The region containing EBER2 was not calculated to have
a favorable z-score; however, this is most likely due to
the inability of the primary sequence alignment to cap-
ture the conservation of structure for this RNA. EBER2
is less conserved in sequence than EBER1 (50.3% sequence
conservation vs. 78.3% for EBER1) making primary se-
quence alignment difficult in this region. Common helices
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Figure 2 Structure models for several known EBV ncRNAs. Nucleotide
the structure. Below are the predicted Gibbs folding free energies (in kcal/m
from the Rfam model (Rfam ID# RF01789) are covered by red Xs, while the m
structures in RNAz-predicted structured region, locus 209, which contains th
Sequences are from the EBV-2 RefSeq (NC_009334.1) genome. (C) Modeledpredicted free energy of the consensus structure, which
resulted in an unfavorable z-score.
All but two of the EBV miRNAs annotated in the
miRBase database [53] occur in RNAz-predicted struc-
tured regions. Each of the mature miRNA sequences,
when mapped to predicted structure models, falls within
a hairpin RNA structure that resembles a canonical pre-
miRNA (Additional files 1 and 3). For example, Figure 2B
shows three hairpins in locus 209, which include the
BART3, BART4, and BART1 miRNAs. Each of these
hairpins places the 5P and 3P mature sequences in ca-
nonical structural contexts: the mature miRNAs are off-
set and imperfectly base pair with each other. This is also
true for the other 36 mature miRNA sequences that fall
within predicted structured regions (Additional file 3).
Finally, a reported EBV-encoded viral small nucleolar
RNA (v-snoRNA; [52]) also falls within an RNAz-predicted
structured region (locus 235 in Additional file 1). The
v-snoRNA corresponds to nt 154352 to 154416 (Additional
file 3) and, in isolation, has a predicted folding free energy
and z-score of -17.8 kcal/mol and -0.81, respectively
(Figure 2C).
In addition to the regions corresponding to EBER1,
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positions for the EBV-2 RefSeq genome sequence are annotated on
ol) and z-scores. (A) EBER1 modeled structure. Base pairs that differ
is-predicted Rfam base pair is indicated with a green line. (B) Modeled
e BART3, BART4, and BART1 miRNAs (indicated in orange boxes).
structure for the viral snoRNA (v-snoRNA) previously reported [52].
Moss and Steitz BMC Genomics 2013, 14:543 Page 4 of 16
http://www.biomedcentral.com/1471-2164/14/543there are 249 additional EBV regions with predicted con-
served RNA structure (Additional file 1).
Structure within introns
Sixty predicted structured regions overlap introns. In-
trons are a fertile source of structured ncRNAs [54,55]
that play roles in a number of important biological pro-
cesses: snoRNAs [56], miRNAs [57], and piRNAs [58]
are expressed from introns. RNA structure within in-
trons can alter accessibility or distance between func-
tional elements and thus regulate splicing [59].
The most extensive regions of predicted structure in
introns occur within a repetitive region of the EBV genome
(the W repeats). The number of W repeats can vary, and
the optimal number appears to be five to eight [60]. The
W repeats are transcribed at the 5′ end of the long
(~100000 nt) primary transcript encoding the Epstein-Barr
nuclear antigen (EBNA) latent proteins (Figure 3). EBNA
transcripts are particularly interesting because they have
high nuclear-to-cytoplasmic abundance, suggesting non-
coding nuclear functions [61].
Six EBNA proteins are expressed from mRNAs pro-
duced by extensive alternative splicing. Transcription of
the EBNA RNA can occur from an upstream promoter,
the C promoter (Cp), or a downstream W promoter
(Wp) [62]. Early in latency III Wp is utilized, where spli-
cing of W0 to W1 generates the start codon for EBNA-
LP production [63]; later in latency III there is a switch
to Cp where the non-coding C2 exon is joined to W1 to
create the EBNA-LP start codon (Figure 3). Within the
W repeats two short coding exons, W1 and W2, which
are 66 and 132 nt long, respectively, are joined to form
the EBNA-LP protein open reading frame (ORF) by re-
moval of a long (2791 nt) and short (81 nt) intron. RNAz
predicts widespread conserved and stable RNA structure
covering 49% of the long W repeat intron. There are fiveW1 W2









Figure 3 Cartoon of the primary transcript encoding the EBNA protei
location of the end of each protein-coding region is indicated above. The
shown in grey. The Cp and upstream Wp promoter sites are indicated by b
sites given above. The boxed region zooms in to show the 5′ end of the p
and ebv-sisRNA-1, colored yellow and green, respectively, with their genom
are shown in blue and labeled L17 to L23 for loci 17 to 23 (genome coordpredicted regions, which are identical in sequence in the
W repeats (Figure 3): loci 18, 23, 28, 33, 38, 43, 48, and
53 are identical; loci 19, 24, 29, 34, 39, 44, 49, and 54 are
identical; loci 20, 25, 30, 35, 40, 45, and 50 are identical;
loci 21, 26, 31, 36, 41, 46, and 51 are identical; and finally,
loci 22, 27, 32, 37, 42, 47, and 52 are identical. Loci 18,
19, and 20, although they are multiplied in the W repeats,
are transcribed only when Cp is used to initiate transcrip-
tion (Figure 3). Cp occurs just upstream of locus 17 and
the C1 non-coding exon is within locus 17 (Figure 3).The
first copy of Wp overlaps locus 21, which also contains
W0 (Figure 3).
Within loci 18, 23, 28, 33, 38, 43, 48, and 53 is a highly
unusual modeled RNA structure, a very long (586 nt)
tetraloop hairpin (Figure 4A). The INFERNAL package
[64,65] was used to search for additional homologous
structures. Three other lymphocryptovirus species [MHV4,
Callitrichine herpesvirus 3 (CaHV3), and Cercopithecine
herpesvirus 12 (CeHV12, also known as papiine herpes-
virus)], members of the herpesvirus taxonomical group to
which EBV belongs (Figure 1), possess homologous struc-
tures. These discovered hairpins occur within the long in-
trons of repeats homologous to the W repeats of EBV,
appearing six times in MHV4 (NC_006146.1 nt 12738 to
13335, 15820 to 16416, 18901 to 19497, 21982 to 22578,
25063 to 25659, and 28144 to 28740) and 4 times in
CaHV3 (NC_004367.1 in the negative strand nt 120959 to
121293, 123871 to 124205, 126783 to 127117, and 129695
to 130029). Three hairpin homologs are found within the
partial sequence of CeHV12 (AF200364.1 nt 6498 to 7112,
9542 to 10156, 12586 to 13200).
The APSI of these long hairpin sequences is 66.7%,
with the CaHV3 sequence being most distant (APSI
45.1% versus EBV). The MHV4 and CeHV12 hairpins
are most similar to EBV in sequence (APSI of 80.5% and
74.5%, respectively) and structure (Figure 4B and C andEBNA-2 -3A -3B -3C EBNA-1





ns. Exons are indicated with black or grey rectangles and the genomic
identical W1 and W2 coding exons that compose most of EBNA-LP are
ent arrows with the genome coordinates of the transcription start
re-mRNA, including the locations of the predicted long hairpin (HP)
e coordinates given in parentheses. RNAz-predicted structured regions
inates for these loci are in Additional file 1).
EBV MHV4 CeHV12 CaHV3
G  = -498.937
o
z-score  = -6.3
G  = -457.337
o
z-score  = -5.9
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G  = -501.037
o
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A DCB Figure 4 Structure models for lymphocryptovirus repeat long
hairpin RNAs. A reported A-to-I editing site [66] is indicated with a red
“I”. Shown are sequences from (A) Epstein-Barr virus (EBV), (B) Macacine
herpesvirus 4 (MHV4), (C) Cercopithecine herpesvirus 12 (CeHV12), and
(D) Callitrichine herpesvirus 3 (CaHV3).
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pins are each capped with a tetraloop closed by a GC
pair (Figure 4A, B, and C) and only the first nt in the
loop varies (UUGG, CUGG, and GUGG, respectively).
The more distant CaHV3 hairpin, in contrast, is capped
with a seven-nt loop (Figure 4D). Perhaps the identities
of the capping nucleotides are of lesser importance to the
function of this long hairpin than the overall conserved
structure, which is marked by extensively base paired
stem regions interspersed with internal (or bulged) loops
(Figure 4). Internal loops may adopt interesting 2D and
3D structures; for example, the three-by-three internal
loop that occurs 20 bps from the hairpin loop in EBV
[Figure 4A, also conserved in MHV4 (Figure 4B)], may
fold into a “3 RRs” motif [67] where the opposing in-
ternal loop nucleotides form consecutive sheared purine-
purine pairs.
Additionally, global thermodynamic z-scores were
calculated for each hairpin (Figure 4): all four have
very negative z-scores (ranging from -6.3 to -5.9).
Thus, the structures generated by these sequences are
more than six standard deviations more thermodynam-
ically stable than random sequences with the same
dinucleotide content. This indicates that evolution is
acting to preserve base pairing within each sequence,
as well as the striking structural homology between
these viral hairpins.
Very long RNA hairpins that are structurally similar
to the EBV W repeat hairpin have been described in
humans [68] and in Caenorhabditis elegans [69]. These
structures are excellent substrates for adenosine deam-
inase acting on RNA (ADAR) editing enzymes, which
convert adenosine to inosine (A-to-I editing). Interest-
ingly, a previous study of A-to-I editing in EBV [66]
found evidence for an editing site that maps to a region
of the genome that we predict to be part of the long
hairpin (Figure 4A). ADARs act on structured RNAs
and have preferences for adenosines in particular se-
quence contexts [70], allowing the prediction of poten-
tial A-to-I editing sites and of the extent of editing.
The reported editing site is predicted to be moderately
edited (12.9% by ADAR2, Additional file 4) and is mod-
eled to be in a CA internal loop (Figure 4A). There are
additional sites predicted to be strongly edited in the
EBV W repeat hairpin and in the homologous struc-
tures found in MHV4, CeHV12, and CaHV3 (Additional
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EBNA-1
Figure 5 Small RNA library RNA-Seq reads aligned with the EBV genome. Reads are colored blue; the EBER1, EBER2, and sisRNA peaks are
much larger than the represented area (see Table 1). A cartoon of the EBV genome is shown in black (exons as boxes and introns as thin lines).
The locations of latently expressed genes [EBNA-LP, LMPs, EBERs (EBER1 and EBER2), BHRF1 miRNAs, and BART miRNAs (clusters I and II)] are
indicated at the top of the figure, including the location of the Cp and first Wp promoter sites for producing mRNA for the EBNA-LP and five
other EBNA proteins (additional details are in Figure 3). Peaks for the ebv-sisRNA-1 and v-snoRNA are indicated. Images were generated using the
integrated genome viewer (IGV, [76,77]) with data from Additional file 5.
Table 1 Regions with significant peaks in aligned RNA-Seq
reads for undigested samples
5′ nt 3′ nt Reads Length (nt) % EBER1*
EBER1 6634 6800 1610 167 100.0
EBER2 6961 7133 415 173 24.9
ebv-sisRNA-1 - - 162 81 20.7
v-snoRNA 154352 154416 49 65 7.8
Short intron 952 1025 41 74 5.7
Short intron 789 870 32 82 4.0
Short intron 459 539 21 81 2.7
Short intron 170112 170189 15 78 2.0
*Percent abundance vs. EBER1.
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which is unsurprising, as selection of ADAR sites may be
partially stochastic [71].
RNA editing in introns, typically within Alu inserts
[71], has been proposed to regulate RNA splicing [72].
Inosine can form wobble pairs with G and C residues and
can contribute to RNA-protein interactions: thus A-to-I
editing can alter important RNA-RNA and RNA-protein
interactions [73]. Editing can alter splicing regulatory ele-
ments or create/destroy splice sites [72]. Perhaps editing of
this long intronic hairpin also plays a role in splicing or in
other functions post-splicing.
Discovery of an EBV-encoded sisRNA
A small RNA library (30-200 nt size range) was cons-
tructed using nuclear RNA isolated from cultured hu-
man B lymphocytes stably infected with EBV (BJAB-B1
cells [74]). These cells exhibit a latency III program of
gene expression, the most transcriptionally active pro-
gram, which also produces latency I and II transcripts.
Nuclear RNAs include not only EBER1 and EBER2 [75]
but also intronic sequences that are excised during the
splicing process. Unsurprisingly, the abundant EBER1
and EBER2 are present in the library and had the highest
number of aligned RNA-Seq reads (Figure 5 and Table 1).
A significant peak (~7.8% EBER1 abundance) corre-
sponding to the v-snoRNA (Figure 5 and Table 1) was
also observed. There was a surprisingly large peak
originating from the W repeat region (Figure 5). This
peak corresponds to reads that cover the entirety of thesmall intron (81 nt) that separates the W1 and W2 ORFs
(Figure 3). Next to the EBERs, this was the largest peak
observed. Comparing length-normalized reads between
the intron and EBER1, the intron is estimated to be present
at 21% the level of EBER1 or roughly on a par with EBER2,
which is estimated to be 25% as abundant as EBER1
(Table 1). The presence of the intron in total nuclear RNA
samples was confirmed by Northern blot (Figure 6A) and
RT-PCR (Figure 6B). RT-qPCR then revealed that the in-
tron is ~9-fold enriched in nuclear versus cytoplasmic
RNA (Figure 6C).
Stable intronic sequence (sis)RNAs have been de-
scribed in Xenopus oocytes [78] and, interestingly, in
herpes simplex virus-1 (HSV-1, an α-herpesvirus) [79]
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Figure 6 Analyses of ebv-sisRNA-1. (A) Northern blot for ebv-sisRNA-1 using RNA from EBV-negative BJAB cells and from isogenic EBV-positive
BJAB-B1 cells. The bottom arrow points to the additional band observed in the EBV-positive BJAB-B1 lane that likely corresponds to the 81 nt
ebv-sisRNA-1, while the upper arrow indicates the 106 nt human U6 snRNA (present in both cell types). (B) RT-PCR for EBER1 and ebv-sisRNA-1 using
cDNA from BJAB-B1 nuclear RNA and primers complementary to the ends of EBER1 and the 5′ end plus nt 52 to 71 of ebv-sisRNA-1. (C) Fold-enrichment
in nuclear versus cytoplasmic RNA as measured by RT-qPCR. Shown are the results for the sisRNA and control 18S and U2 snRNA, which are
cytoplasmically and nuclearly enriched, respectively. Error bars indicate the standard error of three biological replicates, each with three technical
replicates. (D) MAFFT sequence alignment of ebv-sisRNA-1 and those of seven other lymphocryptoviruses: Pongine herpesvirus 1 (PoHV1,
AJ311196.1), Pongine herpesvirus 3 (PoHV3, AJ311194.1), Macacine herpesvirus 4 (MHV4, NC_006146), Cercopithicine herpesvirus 15 (CeHV15,
AJ311199), Herpesvirus MF-1 from Macaca fascicularis (HVMF1, X77781), Cercopithecine herpesvirus 12 (CeHV12, AF200364.1), and Callitrichine
herpesvirus 3 (CaHV3, NC_004367.1). The question mark at the first position in HVMF1 represents missing data, not a true gap. 100% conserved
positions are indicated with stars below the alignment. (E) Predicted structure for ebv-sisRNA-1. Compensatory mutations in the upstream hairpin
that convert a GC pair to an AU pair (in CaHV3) are indicated with bold blue nts. This sequence is repeated seven times in EBV: genome
(NC_009334.1) coordinates 14603 to 14683, 17673 to 17753, 20743 to 20823, 23813 to 23893, 26883 to 26963, 29953 to 30033, and 33023 to 33103.
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associated transcript (LAT) in HSV-1, is implicated in
maintenance of latency [81]. The EBV sisRNA (ebv-
sisRNA-1) is the first of this class of ncRNAs to be de-
scribed in EBV. The ebv-sisRNA-1 differs from the LAT in
two major respects: the LAT is much larger (>2 kb), and
the functional form of the LAT is believed to be the lariat-
intron splicing intermediate, whereas the ebv-sisRNA-1is likely to be a linear molecule. For both ends of ebv-
sisRNA-1 to have been free for ligation in the small RNA
library construction step, the 5′ end of the released intron
could not have been sequestered in a lariat structure. This
suggests that ebv-sisRNA-1 has been acted upon by the
debranching enzyme, which also linearizes intron-derived
snoRNAs during the maturation of this important class of
ncRNAs [82].
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in other lymphocryptoviruses (Figure 6D). The ebv-
sisRNA-1 sequence and these RNAs have an APSI of
83.3%, with the CaHV3 sequence being most distant
(57.6% APSI). In all analyzed EBV strains (EBV-1, EBV-2,
GD1, and GD2), the 81-nt ebv-sisRNA-1 sequence is 100%
conserved, whereas the APSI of the genome sequences of
these strains is 95.6%. Within the CA-rich region an 11-nt
sequence, from positions 49 to 59, is 100% conserved in
the analyzed lymphocryptoviruses (Figure 6D). The distri-
bution of dinucleotide frequencies in the ebv-sisRNA-1 se-
quence is skewed, with CA being the most frequent,
followed by AC and CC. The presence of CA-rich regions
in the sisRNA is interesting as such sequences are able to
bind hnRNP L protein and modulate splicing [83].
Although ebv-sisRNA-1 did not overlap an RNAz-
predicted region, the secondary structure for this RNA
was modeled on the basis of the eight sequences shown in
Figure 6E. Two small hairpins are predicted (Figure 6E): an
upstream hairpin that places the U-rich motif in a loop
and a weak (3 base pair) hairpin in the CA-rich region.
A compensatory mutation (double point-mutation that
preserves base pairing) is observed in the more stable
upstream hairpin (Figure 6E, a conserved GC pair is
converted to a UA pair in CaHV3), which suggests
that evolution is acting to preserve this structure. It isTable 2 EBV short intron predicted free energies and z-scores
5′ nt 3′ nt Length APSIa (%)
273 359 87 99.4
459 539 81 96.9
789 870 82 100.0
952 1025 74 100.0
1197 1279 83 100.0
1496 1573 78 99.4
11466 11610 145 99.2
14939 14541 149 98.2
14603b 14683b 81 100.0
35474 35557 84 97.0
71968 72073 106 100.0
80362 80446 85 94.3
83431 83508 78 97.0
87014 87087 74 99.3
90856 90940 85 95.9
91046 91196 151 82.9
105929 106056 128 96.2
169949 170024 76 95.0
170112 170189 78 98.3
aAPSIs calculated for four EBV strains (EBV-1, EBV-2, GD1, and GD2).
bNucleotide numbers for first instance of ebv-sisRNA-1.interesting to find evidence of a conserved hairpin that
places the U-rich motif in a loop, as U-rich sequences
often bind proteins [84] and hairpins can pre-organize
RNA sequence motifs for RNA-protein interactions [85].
The CA-rich region is likely unstructured and free to as-
sociate with other interactors.
Additional putative sisRNAs in EBV
Other than the W repeat sisRNAs, EBV possesses 18
additional short introns (Table 2) interspersed through-
out its genome. These short introns range in conserva-
tion from 82.9% to 100.0% APSI (average of 97.2%) and
are predicted to fold into structures with a range of
thermodynamic stabilities (from -0.4 to -59.6 kcal/mol).
Four sequences have significantly negative z-scores [< -1.0,
from nt 11466 to 11610, 80362 to 80446, 87014 to 87087,
and 105929 to 106056 (Table 2)] and one intron has a
moderately favorable z-score (-0.54) from nt 1496 to 1573.
These short introns also overlap with RNAz-predicted
structured regions (Table 2).
Particularly interesting is the sequence from nt 105929
to 106056, which has the most favorable predicted fold-
ing free energy and z-score of any EBV intron (Table 2).
This intron occurs within the lytically-expressed BBLF2/3
gene, which generates part of a helix-primase complex
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http://www.biomedcentral.com/1471-2164/14/543modeled secondary structure of the intron is shown in
Figure 7A; it forms a tetraloop hairpin that includes
all of the intron sequence. This intron structure is
contained within RNAz-predicted locus 152, where the
basal stem of the hairpin extends into coding regions by
25 nt (Additional file 3, nt 66692 to 66844 in the reverse
genome sequence) and the splice donor and acceptor are
base paired within helices. A similar hairpin structure,
identified by INFERNAL, occurs in the MHV4 genomeCUAGGCU-3'5'-CAGGU 5
EBV
G  = -59.637
o




Figure 7 Hairpin structure predicted in BBLF2/3 mRNA. (A) Hairpin mo
sites are indicated with dark and light blue arrows, respectively. Nucleotide
models in Additional file 3 (locus 152). The predicted free energy (in kcal/m
structure in MHV4. The BBLF2 translation stop codon is shaded in red and(Figure 7B). Rather than being joined together via spli-
cing, MHV4 BBLF2/3 is translated from two ORFs
that produce BBLF2 and BBLF3 as separate proteins.
This same intronic region in EBV partially codes for
BBLF2 in MHV4 (the translation stop codon occurs
within the UUAA tetraloop) and is also present in the
5′ UTR of BBLF3 (Figure 7B). It is remarkable that the
hairpin structure has been maintained evolutionarily be-
tween EBV and MHV4 despite different apparent roles in'-CGGGU UCUAGGCA---35nt---
MHV4
G  = -56.737
o




deled for the EBV BBLF2/3 short intron. Splice donor and acceptor
numbers in parentheses correspond to the reverse genome strand
ol) and z-score of the hairpin are shown. (B) Homologous hairpin
the BBLF3 start codon is shown in green.
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http://www.biomedcentral.com/1471-2164/14/543protein expression: in EBV it brings splice sites closer
together in space and may be processed out to form an
independent structured RNA, whereas in MHV4 it pre-
sents a stop codon in a loop and is not processed out
of the mRNA.
Four EBV short introns have significant numbers of
mapped reads in the small RNA library (Table 1); how-
ever, they are lower in abundance than ebv-sisRNA-1. In
the EBV latent membrane protein (LMP-2B) gene, for
example, there are three short introns with significant
numbers of aligned read peaks (nt 459 to 539, nt 789 to
870, and nt 952 to 1025 in Table 1). Indeed, the intron
encompassing nt 952 to 1025 has an abundance of ~5.7%
relative to EBER1, which is similar to the value observed
for the v-snoRNA (7.8%, Table 2). The short introns in
EBV, including those that are expressed during latency III
and those with few or no mapped reads, may represent a
family of sisRNAs. It will be interesting to learn if they are
differentially expressed in other viral latency programs or
during the lytic phase. Short introns are an attractive
source of small ncRNAs, as they are released as by-
products of pre-mRNA splicing.
Structure overlapping splice sites
The importance of RNA structure in the regulation of
splicing has been highlighted in two excellent reviews
[59,87]. Structure can be inhibitory, by sequestering
splice sites [88] or regulatory elements [89], or it can en-
hance splicing by presenting sites in an accessible conform-
ation [90] or by bringing splice sites into closer proximity
with each other [91]. Conformational switching between
accessible and inaccessible structures may also regulate
splicing [92].
In EBV, there are seven predicted structured regions
that include splice sites (Additional file 1). Of these, three
include a splice donor or acceptor, while the remaining
regions include both sites. For example, in the LMP-2BG  = -52.5 37
o










Figure 8 Predicted RNA structures containing splice sites and a start c
(in LMP-2B gene). The splice donor site is indicated with a dark blue colored
(B) Structure model for locus 2 (in the LMP-2B gene). The splicing acceptor
indicates a putative exonic splicing enhancer. (C) Structure model for locus
indicated by the green box.gene, locus 1 overlaps a splice donor site (after nt 788,
Additional file 3), which is buried within the stem of
a tetraloop hairpin; towards the 3′ end of this struc-
ture (nt 827 to 833) is a putative intronic splicing en-
hancer (Figure 8A). Locus 2 spans an entire intron
and includes both the donor and acceptor sites (after
nt 1495 and 1573, respectively, in Additional file 3).
Additionally, there is a putative exonic splicing enhan-
cer at the beginning of locus 2 (nt 1475 to 1482). The
modeled structure for locus 2 (Figure 8B) organizes
this region into a complex multibranched structure
where the splice donor and acceptor sites are each in
helices: the donor at the end of the basal stem and the
acceptor within a hairpin loop. Interestingly, each splice
site occurs directly after or near a predicted UU/UU two-
by-two internal loop motif, in which UU mismatches
maintain stable [93,94] helical 3D conformations [95].
Internal loops and non-canonical pairs can present com-
plex patterns of chemical functional groups in protein-
accessible regions of a folded RNA [96], which may
influence the binding of splicing factors. Additionally,
the 3D folding of this structure may bring splice sites
close together .
Structure overlapping coding regions
Many (150) predictions overlap EBV coding regions, in
some cases including a significant portion of an ORF. In
the lytically-expressed EBV FGAM-synthase gene, for
example, predictions cover 40% the coding nt (locus 3
to locus 9; Additional file 1). More dramatically, the
BGLF3 gene overlaps four predicted structured regions
(locus 163 to locus 166; Additional file 1), which span
84% of the coding region including part of the start
codon. Interestingly, many viral genomes appear to be
enriched for RNA secondary structure [97,98], includ-
ing within coding regions [38,99,100]. RNA structure in







G  = -33.0 37
o
z-score  = -2.37
5'
3'
G  = -20.8 37
o






odon. (A) Structure model for RNAz-predicted structural region locus 1
wedge and a putative intronic splicing enhancer is colored yellow.
site is indicated with the light blue wedge and the yellow box now
263. The start codon for latent membrane protein 2A (LMP-2A) is
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[37] or by inducing ribosomal pausing [102], which can
impact numerous co-translational processes [103,104].
The identification of conserved and stable RNA second-
ary structures within EBV coding regions suggests that
they may play important roles in this virus.
Twenty-one predicted structured regions include trans-
lation start or stop codons. Locus 263, for example,
includes the start codon for the latent membrane protein
2A (LMP-2A), which is involved in the regulation of host
B-cell signaling and is implicated in EBV-associated
tumorigenesis [105]. The first 63 nt of locus 263 fall
within the 5′ UTR of the LMP-2A mRNA (Figure 8C).
The start codon is predicted to occur within the stem
helix of a multibranch loop. RNA structure can play a
role in regulating translation through modulating the
accessibility of codons. Strong RNA structure at stop
codons, for example, can stimulate stop codon read-
through [106], whereas modulation of start codon acces-
sibility can affect translational efficiency [107]. Perhaps
the stable structure (z-score -1.48, Figure 8C) that en-
compasses the LMP-2A start codon modulates the ex-
pression of this important gene.
Conclusion
Bioinformatics analyses of the EBV genome revealed
265 regions with putative conserved RNA structure.
The computational screen successfully identified most
of the known EBV ncRNAs: EBER1, a virally-encoded
snoRNA, and 42 miRNAs. Other predicted structured
regions of the EBV genome occur at or near sites
that suggest potential functions for RNA structures.
A very long hairpin structure in the W repeat region
that is conserved in lymphocryptoviruses contains at
least one A-to-I editing site, with possible implica-
tions for splicing. Additional regions span splice sites
or start and stop codons. These structure predictions
may prove useful since RNA and RNA structures are
attractive targets for chemotherapy [108-111]. The
modeled RNA structures are rich in internal loops, e.g.
the UU/UU internal loops near two splice sites in
LMP-2B, which are potentially drugable structural mo-
tifs [112]. RNA splicing, in particular, is an attractive
target for RNA therapeutics [113,114].
RNA-Seq data identified several putative sisRNAs, in-
cluding one in the W repeat region (ebv-sisRNA-1) that
is abundant and localizes in the nucleus. These results
lay the groundwork for future experiments to further
characterize the proposed structures and to understand
the functional significance of the discovered RNAs and
RNA structures in EBV. All structural data are available
in the Additional files. In addition, data for the W repeat
long hairpin and ebv-sisRNA-1 will be deposited in the
Rfam database.Methods
Structure prediction and modeling
EBV RefSeq genomes from four different viral strains,
EBV-1 (NC_007605.1), EBV-2 (NC_009334.1), GD1
(AY961628.3), and GD2 (HQ020558.1), plus one
closely-related genome from Macacine herpesvirus 4
(NC_006146.1), were obtained from the NCBI nt data-
base. Genome sequences were aligned using the MAFFT
program [49,50] implementing the FFT-NS-1 alignment
strategy. The alignment was processed into 120-nt
windows with a 10-nt step-size using the Perl script
rnazWindow.pl provided with the RNAz program. Pre-
dictions of windows with likely conserved and stable
RNA structure were made for both the plus and minus
strands with the RNAz 2.1 [42,44] program using a di-
nucleotide randomization model. The RNAz output
was processed to combine windows with higher prob-
ability of structure (p-class > 0.5) into loci. These loci
were further filtered to include only those that had at
least one window with p-class > 0.9. When predictions
had ambiguous strand orientations, e.g. occurred in a
genome location that could be transcribed from either
strand, the program RNAstrand [115] was used to de-
termine if structure was more likely to be in the for-
ward or reverse strand.
From each predicted locus the EBV-2 sequence was
extracted and used in a BLAST [116] search against the
NCBI nt database. The returned homologous sequences
were compiled and each locus was aligned using the
MAFFT program implementing the Q-INS-i method.
Initial models for these alignments were made using
RNAalifold [117]. Alignments and predicted consensus
structures were converted to Stockholm format alignments
and used to build covariance models with the INFERNAL
package [64]. These covariance models were used to
search for potentially homologous sequences/structures in
a database of all available herpesvirus RefSeq genomes.
Returned sequences were added to the alignments and
structural predictions were made using RNAalifold as
well as the program TurboFold [118] followed by manual
model refinement. Resulting models were used to per-
form additional iterative INFERNAL searches and struc-
ture revisions until no further model improvement could
be made (finding the structure that was best conserved in
the alignment).
2D renderings of modeled RNAs were generated using
the PseudoViewer program [119] and manually processed
using the open-source graphics program Inkscape and
ImageJ [120,121]. The Gibbs free energy of folding at
37°C [122,123] for models was calculated using the
efn2 method implemented in the RNAstructure pack-
age [124]. The z-scores for sequences were calculated
by generating sets of 200 dinucleotide randomiza-
tions using the SIMMONICS program [125] and then
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ence in native free energy versus the randomized set
was normalized by the standard deviation to give the
z-score.
Small RNA-Seq analysis
EBV-positive BJAB-B1 cells were maintained at 37°C and
5% CO2 in RPMI media supplemented with FBS (10%)
and penicillin [20]. Cells that had been expanded from
1 ml frozen stock to 200 ml culture volume were grown
for an additional 48 hrs and were then pelleted by cen-
trifugation at 1000 × g for 5 min at 4°C. Pellets were
washed 3× with ice-cold PBS buffer (plus DTT). The
pellet, on ice, was resuspended in cell disruption buffer
[127] (10 mM KCl, 1.5 mM MgCl2, 20 mM Tris-Cl,
1 mM DTT, 0.1% Triton-X) and moved to a chilled
Dounce homogenizer (Kontes, type B). Homogenization
proceeded on ice until mostly free nuclei were observed
under microscope. The lysate was transferred to centri-
fuge bottles and spun at 1500 × g for 5 min at 4°C. The
supernatant, containing the cytoplasmic fraction, was re-
moved to a fresh tube and a 3× volume of Trizol reagent
was added. The nuclear fraction containing pellet was
dissolved in 3 ml of Trizol reagent and both fractions
were flash frozen in a dry-ice/ethanol bath and stored
at -80°C overnight. Each sample was chloroform extracted
and then precipitated at room temperature for 10 min
using isopropanol. RNA was pelleted by centrifugation at
10000 × g for 10 min at 4°C. Pellets were resuspended in
water and treated with RNase-free DNase I according to
manufacturer’s protocol (Promega). RNA was further puri-
fied/recovered by RNeasy RNA purification kit (Qiagen).
Samples were treated again using DNase I to remove any
traces of genomic DNA contamination and recovered
using the RNeasy kit. RNA integrity was checked using an
Agilent BioAnalyzer: the RNA integrity number for the un-
digested samples was equal to 10, indicating that sample
annealing did not degrade the RNA. RNA samples were
used to build libraries using a small RNA library kit
(Illumina), where specific adapters were ligated to the
5′ and 3′ ends, before barcoding and cDNA synthesis.
The cDNA was fragmented and size-selected to contain
fragments in the range of 30 to 200 bp. RNA-Seq data,
75 bp reads, were acquired on an Illumina HiSeq instru-
ment run in paired-end mode. Reads were aligned to the
EBV-2 RefSeq genome (NC_009334.1) using the Bowtie 2
program [128] (data given in Additional file 5).
Analysis of ebv-sisRNA-1 expression
20 μg of total RNA from EBV-positive BJAB-B1 and
EBV-negative (but otherwise isogenic) BJAB cells were
fractionated by denaturing 10% PAGE. RNA was trans-
ferred to an Amersham Hybond-N + positively charged
nylon membrane then cross-linked to the membraneusing UV radiation. The membrane was incubated at 37°C
for 1 hr in pre-hybridization buffer (GE) and washed 3× in
double-distilled water (ddH2O). The membrane was then
incubated overnight at 37°C with 5′-radiolabeled DNA
probe complementary to nts 37 to 66 of the 106 nt human
U6 snRNA (NR_046494.1), probe sequence: 5′-GCAGG
GGCCATGCTAATCTTCTCTGTATCG-3′. The blot was
washed 3× in wash buffer (0.005% SDS and 3× SSC),
wrapped in plastic film, exposed to a phosphor screen
for 16 hrs and imaged on a Storm phosphorimager.
The blot was rehybridized with 5′-radiolabeled DNA
probe complementary to nt 19 to 46 of ebv-sisRNA-1,
probe sequence: 5′- TGTGGTGGAGTGTTGGGCTTA
GCAGAAA -3′.
For the RT-PCR and RT-qPCR analyses, 2 μg nuclear or
cytoplasmic RNA were used to generate cDNA with the
High Capacity cDNA synthesis kit (Applied Biosystems).
5 μl 100× diluted cDNA was used for PCR with EBER1
primers complementary to the transcript’s 5′ and 3′ ends:
FWD 5′-AGGACCTACGCTGCCCTAGA-3′ REV 5′-AA
AACATGCGGACCACCAGCTGG-3′, and ebv-sisRNA-1
primers complementary to the 5′ end and nt 52 to 71:
FWD 5′-GTAAGTGGACTTTAATTTTTTCTGCTAA
GCCC-3′ REV 5′-TGGGTGTGTGTAGTGTGTGC-3′.
Template was combined with 5 μl 10× PCR buffer
(NEB), 1 μl 10 mM dNTPs, 1 μl each of 10 μM primer and
0.25 μl Taq (NEB) and ddH2O to a final volume of 50 μl.
The thermocycler protocol was: (i) initial denaturation at
90°C for 10 min, (ii) melt at 90°C for 15 s, (iii) anneal
at 53°C for 30 s, (iv) extend at 60°C for 30 s, (v) cycle
back to step ii 40×. Amplification products were analyzed
by denaturing 10% PAGE and stained with ethidium
bromide. Amplicon sizes were determined by comparison
to a 10 bp ladder (Invitrogen).
For RT-qPCR a master mix was made of FastStart
Universal SYBR Green Master Mix (Roche), ddH2O and
each primer (final concentration of 300 nM). 45 μl ali-
quots were added to a 96-well plate before adding 5 μl
100× dilute cDNA (three biological replicates, each run
with three technical replicates, including no template and
reverse transcriptase controls). In addition to the ebv-
sisRNA-1 primers, amplification of nt 8 to 104 of the
nuclear-enriched U2 snRNA (NR_002716.3) used primers:
FWD 5′-CTCGGCCTTTTGGCTAAGAT-3′ REV 5′-TA
TTCCATCTCCCTGCTCCA-3′; and nt 994 to 1071 of
the cytoplasmically-enriched 18S rRNA (NR_003286.2)
used primers: FWD 5′-CGAAAGCATTTGCCAAGA
AT-3′ REV 5′-GCATCGTTTATGGTCGGAAC-3′. The
same thermocycler protocol used for PCR was used for
the qPCR run, and data was collected on an Applied
Biosystems StepOnePlus Real-Time PCR system. Data
were exported to Microsoft Excel and analyzed using the
Delta Ct method to find the ratio of nuclear to cytoplas-
mic abundance.
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Additional file 1: Table showing RNAz-predicted regions with likely
stable and conserved RNA structure. Annotated regions (e.g. splice
sites and miRNAs) are highlighted in different colors, which match
color-annotated structure models provided in Additional file 3 with start and
stop codons in green and red, respectively; splice sites in blue; miRNAs in
orange; the W repeat hairpin in yellow; EBER1 in purple; and the v-snoRNA in
brown. The columns for the 5′ and 3′ nt are the first and last nt of the EBV
genome (NC_009334.1) that comprise the predicted structured region. The 5′
and 3′ nt-Rev numbers indicate the location of structure that likely occurs in
RNA transcribed from the reverse genome sequence (corresponding to the
structure models shown in the REV_STR worksheet in Additional file 3).
Additional file 2: BED file with locations of RNAz-predicted
structured regions.
Additional file 3: Spreadsheet showing structure models for
predicted EBV structured regions. The sequence shown is for the
EBV-2 strain (NC_009334.1). In EBV, transcription can occur from either
DNA strand and results for the forward and reverse sense genome
sequences are presented in separate worksheets (FWD_STR and REV_STR).
RNA structures are in “dot-bracket” notation, with paired sites indicated
with matched brackets and unpaired with dots. Colored regions
correspond to annotated RNAs in Additional file 1.
Additional file 4: Structure models and predictions of possible
A-to-I editing sites (using the Inosine Predict program [70]) for
lymphocryptovirus repeat long hairpin RNAs. Each virus has a
separate listing with nt position numbered for just the hairpin,
followed by the sequence, the secondary structure in dot-bracket
notation, the calculated percent editing for four ADAR specificities,
and the maximum predicted value of all ADAR specificities. A
reported A-to-I editing site [66] is colored red.
Additional file 5: BED file with aligned RNA-Seq reads from
BJAB-B1 nuclear small RNA sample.
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